Back
Range Cancer Therapeutics ETF Vs. JD.com Industry Stock Comparison
Sell
38
CNCR
Range Cancer Therapeutics ETF
Last Price:
14.92
Seasonality Move:
-2.75%
Buy
85
JD
JD.com
Last Price:
39.91
Seasonality Move:
2.36%
Sell
38
Range Cancer Therapeutics ETF (CNCR)
is a Sell
Is Range Cancer Therapeutics ETF a Buy, Sell or Hold?
- The current Range Cancer Therapeutics ETF [CNCR] share price is $14.94. The Score for CNCR is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- CNCR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
85
JD.com (JD)
is a Buy
Is JD.com a Buy, Sell or Hold?
- The current JD.com [JD] share price is $37.99. The Score for JD is 85, which is 70% above its historic median score of 50, and infers lower risk than normal.
- JD is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
CNCR Stock Price Chart
What is Range Cancer Therapeutics ETF's stock price today?
-
The Range Cancer Therapeutics ETF share price today is $14.94
The current trend is moderately bearish and CNCR is experiencing buying pressure, which is a positive indicator for future bullish movement.
CNCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.13 | Buy |
| Relative Strength Index (14 RSI): | 48 | Sell |
| Chaikin Money Flow: | 1445 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.66 - 15.58) | Sell |
| Bollinger Bands (100): | (13.97 - 15.37) | Buy |
JD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.85 | Buy |
| Relative Strength Index (14 RSI): | 83.58 | Buy |
| Chaikin Money Flow: | 36035340 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (24.86 - 30.7) | Buy |
| Bollinger Bands (100): | (25.63 - 31.13) | Buy |
CNCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.31 | Sell |
| 20-day SMA: | 15.15 | Sell |
| 50-day SMA: | 14.83 | Buy |
| 200-day SMA: | 14.82 | Buy |
| 8-day EMA: | 15.19 | Sell |
| 20-day EMA: | 15.15 | Sell |
| 50-day EMA: | 14.91 | Buy |
| 200-day EMA: | 14.47 | Buy |
JD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 30.75 | Buy |
| 20-day SMA: | 28.15 | Buy |
| 50-day SMA: | 27.11 | Buy |
| 200-day SMA: | 26.99 | Buy |
| 8-day EMA: | 31.87 | Buy |
| 20-day EMA: | 29.26 | Buy |
| 50-day EMA: | 27.97 | Buy |
| 200-day EMA: | 28.53 | Buy |
Range Cancer Therapeutics ETF Earnings Growth & CNCR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
JD.com Earnings Growth & JD Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.24 per share, an increase next quarter of $0.25 per share, an increase this year of $1.01 per share, and an increase next year of $0.23 per share.
Range Cancer Therapeutics ETF Technical Analysis
| Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
JD.com Technical Analysis
| Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||